(R)-tert-Butyl 4-(2-chloroacetyl)-3-(hydroxymethyl)piperazine-1-carboxylate

Catalog No.: 
ACLEVB932
CAS No.: 
1147422-39-6
Molecular Formula: 
C12H21ClN2O4
Molecular Weight: 
292.76
(R)-tert-Butyl 4-(2-chloroacetyl)-3-(hydroxymethyl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$819.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl 4-(2-chloroacetyl)-3-(hydroxymethyl)piperazine-1-carboxylate
IUPAC Nametert-butyl (R)-4-(2-chloroacetyl)-3-(hydroxymethyl)piperazine-1-carboxylate
MDL No.MFCD28001044
Molecular FormulaC12H21ClN2O4
Molecular Weight292.76
SMILESO=C(N1C[C@H](CO)N(C(CCl)=O)CC1)OC(C)(C)C
InChI KeyBNTGHZXNGKLANJ-SECBINFHSA-N
Synonym1-Piperazinecarboxylic acid, 4-(2-chloroacetyl)-3-(hydroxymethyl)-, 1,1-dimethylethyl ester, (3R)-
CAS No.1147422-39-6

Synthetic Route by SureRoute

1. ACLEVB932 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLIJP362 route compound structure diagram
    ACLIJP362278788-66-2In Stock
  2. Plus
  3. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8In Stock
  4. Then
  5. ACLEVB932 route product structure diagram
    ACLEVB9321147422-39-6
Inquiry

2. ACLEVB932 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLIJP362 route compound structure diagram
    ACLIJP362278788-66-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLEVB932 route product structure diagram
    ACLEVB9321147422-39-6
Inquiry

3. ACLEVB932 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLIJP362 route compound structure diagram
    ACLIJP362278788-66-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLEVB932 route product structure diagram
    ACLEVB9321147422-39-6
Inquiry

Comments (0)